The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of preoperative docetaxel, cisplatin, and capecitabine in patients with gastric carcinoma.
Pei-Jye Voon
No relevant relationships to disclose
Mu-Yar Soe
No relevant relationships to disclose
Ying Kiat Zee
No relevant relationships to disclose
Benjamin Chuah
No relevant relationships to disclose
Robert S. C. Lim
No relevant relationships to disclose
Asim Shabbir
No relevant relationships to disclose
Jimmy So
No relevant relationships to disclose
Wei-Peng Yong
No relevant relationships to disclose